HIV Drug Descovy May Increase Risk of High Blood Pressure: Study
Researchers warn that the hypertension risks linked to Descovy appear to increase with the age of the patient.
Tag Archives: Descovy
-
-
U.S. Task Force Finds “High Benefit” from Use of HIV Drugs for Prevention
Properly identifying patients at higher risk of transmission increases the benefits of prescribing certain HIV drugs as prophylactics, researchers determined.
-
Lawsuit Over Atripla, Truvada Pay-to-Delay Generics Scheme Results in Defense Verdict for Gilead, Teva
This is the third antitrust trial victory for Gilead involving claims it participated in an Atripla and Truvada pay-to-delay generics scheme
-
Government’s Gilead HIV Drug Lawsuit Over Patent Rights Ends in Defense Verdict
The Gilead HIV drug lawsuit filed by the Justice Department claimed the drug maker violated patents held by the CDC for the use of Truvada and Descovy as preventative treatments.
-
Lawsuit Alleges Side Effects of Atripla, Stribild and Other HIV Drugs Endangered Patients to Increase Gilead Profits
Plaintiffs say kidney and bone injuries could have been avoided if Gilead had marketed its safer formulation to avoid the side effects of Atripla, Stribild and other HIV drugs.
-
Gilead HIV Drug Health Risks Were Known Before First TDF-Based Antiretrovirals Hit The Market: Lawsuit
Earlier Gilead antiviral drugs using similar molecular formulations carried black box warnings due to the risks of kidney damage.
-
HIV Drug Settlement Reached to Resolve Class Action Over Truvada, Stribild, Other Antiretrovirals
Bristol-Myers Squibb has agreed to pay $10 million to resolve its part in the class action lawsuit over HIV drugs with allegedly inflated prices.
-
Gilead TDF Lawsuit Alleges Toxic Effects of HIV Drugs on Bones, Kidneys Was Known For Years
This and similar lawsuits claim Gilead sat on a safer formulation of its HIV drug for years in order to maximize its profits from the older, more toxic version.
-
Gilead Knew HIV Drug Compound TDF Was Toxic to Kidneys and Bones, Lawsuit Alleges
Lawsuit indicates Gilead sat on safer drug formulations until it completely cashed in on the older, more dangerous TDF-based HIV drugs.
-
Gilead Class Action Lawsuit Over TDF-Based HIV Drugs Allowed to Move Forward
